WTA
Washington Trust Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.7M | Buy |
29,961
+435
| +1% | +$228K | 1.28% | 24 |
|
|
2025
Q1 | $18.7M | Buy |
29,526
+236
| +0.8% | +$150K | 1.66% | 20 |
|
|
2024
Q4 | $20.9M | Sell |
29,290
-89
| -0.3% | -$63.4K | 1.74% | 17 |
|
|
2024
Q3 | $30.9M | Sell |
29,379
-106
| -0.4% | -$111K | 2.66% | 12 |
|
|
2024
Q2 | $31M | Sell |
29,485
-1,211
| -4% | -$1.27M | 2.85% | 10 |
|
|
2024
Q1 | $29.5M | Sell |
30,696
-1,529
| -5% | -$1.47M | 2.71% | 11 |
|
|
2023
Q4 | $28.3M | Sell |
32,225
-371
| -1% | -$326K | 2.71% | 12 |
|
|
2023
Q3 | $26.8M | Sell |
32,596
-295
| -0.9% | -$243K | 2.75% | 11 |
|
|
2023
Q2 | $23.6M | Sell |
32,891
-120
| -0.4% | -$86.2K | 2.29% | 15 |
|
|
2023
Q1 | $27.1M | Sell |
33,011
-155
| -0.5% | -$127K | 2.76% | 9 |
|
|
2022
Q4 | $23.9M | Sell |
33,166
-994
| -3% | -$717K | 2.62% | 11 |
|
|
2022
Q3 | $23.5M | Sell |
34,160
-358
| -1% | -$247K | 2.2% | 12 |
|
|
2022
Q2 | $20.4M | Buy |
34,518
+31
| +0.1% | +$18.3K | 1.8% | 18 |
|
|
2022
Q1 | $24.1M | Sell |
34,487
-419
| -1% | -$293K | 1.71% | 19 |
|
|
2021
Q4 | $22M | Buy |
+34,906
| New | +$22M | 1.49% | 25 |
|